News Focus
News Focus
Followers 48
Posts 23523
Boards Moderated 0
Alias Born 09/16/2012

Re: None

Friday, 10/10/2025 6:29:45 PM

Friday, October 10, 2025 6:29:45 PM

Post# of 821143
LP and the disciples just forget to tell investors that.🤷‍♀️

>>However, a potential downside to this form of therapy is that it can create a pro-inflammatory environment within the tumor that can mitigate the impact of the vaccine by creating an immune tolerance instead of an immune response. Dr. Liau and Dr. Prins are now researching how to address this issue, namely by studying the interactions that occur on a local cellular level. They postulate that these micro-interactions are a critical factor in the efficacy of immunotherapies in glioblastoma patients. Additionally, they hope that their research can provide more insight into impactful ways to induce therapeutic anti-tumor immune responses for glioblastoma.)
UCLA Brain SPORE Project 2
Despite these potential setbacks, Dr. Prins is optimistic about immunotherapeutic interventions to treat
glioblastoma. "Immunotherapy is theoretically one of the best new treatments that can target isolated tumor cells before they metastasize elsewhere," said Dr. Prins. "I think immunotherapies are going to be the next new revolution in this cancer therapy."
The other two SPORE projects target different aspects of brain cancer.…

https://hotb.org/wp-content/uploads/2022/05/spore-article-for-donors-4.18.22.pdf
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News